Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > BFRI Biofrontera > Detailed Quotes

BFRI Biofrontera

Watchlist
0.918
-0.007-0.76%
Close  01/27 16:00 ET
0.9180.0000.00%
Post Mkt Price 01/27 17:10 ET
High
0.930
Open
0.910
Turnover
58.15K
Low
0.850
Pre Close
0.925
Volume
64.56K
Market Cap
24.52M
P/E(TTM)
Loss
52wk High
6.120
Shares
26.70M
P/E(Static)
Loss
52wk Low
0.750
Float Cap
14.12M
Bid/Ask %
-33.33%
Historical High
14.630
Shs Float
15.38M
Volume Ratio
1.09
Historical Low
0.750
Dividend TTM
--
Div Yield TTM
--
P/B
1.09
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.42%
Amplitude
8.65%
Avg Price
0.900
Lot Size
1
Float Cap
14.12M
Bid/Ask %
-33.33%
Historical High
14.630
Shs Float
15.38M
Volume Ratio
1.09
Historical Low
0.750
Dividend TTM
--
P/B
1.09
Dividend LFY
--
Turnover Ratio
0.42%
Amplitude
8.65%
Avg Price
0.900
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company is focused on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.
CEO: Ms. Erica Monaco, C.P.A.
Market: NASDAQ
Listing Date: 10/29/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist